Avtor/Urednik		Štorman, Alenka
Naslov		Kakšne so možnosti za razvoj proti vankomicinu odpornih enterokokov
Tip		članek
Vir		In: Dragaš AZ, Lorenčič-Robnik S, Kotnik-Kevorkijan B, editors. Zbornik predavanj Bolnišnične okužbe; 1999 maj 21-22; Maribor. Maribor: Splošna bolnišnica Maribor,
Leto izdaje		1999
Obseg		str. 183-96
Jezik		slo
Abstrakt		Enterococcci are naturally (intrinsically) resistant to a large number of antibiotics. In addition to their intrinsic resistances, enterococci posess a remarkable ability to develop new mechanisms of resistance. Vancomycinresistant enterococci were first identified in Europe in 1986 and a year later in the USA. There are four phenotypes (A, B, C and D) of VRE. Nosocomial outbreaks with VRE have become increasingly common especially in USA. The measures to limit VRE spread have failed on occasion. An increased risk of VRE infection and colonization has been associated with previous vancomycin and multiantimicrobial therapy or both. Colonized and infected patients represent sources for nosocomial infection. Enviromental surfaces, medical equipment and supplies may become contaminated and serve as reservoirs for VRE in the hospital. In contrast to findings in Europe, VRE are not part of the routine human flora in USA. The use of glycopeptide growth promotors in Europe may have selected for VRE in animals and subsequently in humans.
Deskriptorji		ENTEROCOCCUS DRUG RESISTANCE, MICROBIAL VANCOMYCIN CARRIER STATE GRAM-POSITIVE BACTERIAL INFECTIONS GLYCOPEPTIDES MICROBIAL SENSITIVITY TESTS ANTIBIOTICS ENTERAL NUTRITION INTENSIVE CARE UNITS RISK FACTORS